ET-51 COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

BACKGROUND: Expression of chemokine receptor CXCR4 and its ligand stromal cell-derived factor-1α (SDF-1α) is enhanced in glioblastoma, including at invasive edges, and associated with proliferation, invasion and angiogenesis (Zagzag, 2008; Ehtesham, 2013; Gagliardi, 2014). Using Protein Epitope Mime...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sarfraz, Yasmeen, Alotaibi, Fawaz M., Ortenzi, Valerio, Tayyib, Awab T., Douglas, Garry J., Chevalier, Eric, Romagnoli, Barbara, Tuffin, Gérald, Gagner, Jean-Pierre, Zagzag, David
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218146/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou255.48
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki